20331 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles Imidazole-alkylamines, e.g. histamine, phentolamine
ABAD INHIBITOR COMPOUNDS
#2AZOLE DERIVATIVES AS SHP2 INHIBITORS
#3DUAL INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#4COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH
#5POLYMORPHIC FORM OF NEPICASTAT ACID ADDITION SALT, PREPARATION METHOD THEREFOR AND USE THEREOF
#6GAMMA-SECRETASE INHIBITORS FOR USE IN THE TREATMENT OF INHERITED EPIDERMOLYSIS BULLOSA
#7COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#8CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
#9TREATMENT OF MULTIPLE MYELOMA
#10COMPOSITIONS AND METHODS FOR TREATING CANCER
#11TOPICAL COMPOSITION
#12ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DISEASE
#13Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof
#14REACTIVE OXYGEN SPECIES MODULATION THROUGH BINDING OF LIGANDS AT THE NQ-BINDING SITE OF THE RESPIRATORY COMPLEX III
#15THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS
#16DEVICES, SYSTEMS, KITS, AND METHODS FOR DRUG DELIVERY TO THE SPINAL CORD
#17AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
#18AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
#19AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
#20BIOACTIVE POLYMERIC DRESSING FOR ACCELERATED WOUND CLOSURE
#21PHENTOLAMINE MESYLATE AND THERAPEUTIC USES THEREOF
#22METHODS AND COMPOSITIONS FOR TREATMENT OF MYDRIASIS
#23METHODS AND COMPOSITIONS FOR TREATMENT OF MYDRIASIS
#24PATHWAY MODULATOR, PHARMACEUTICAL COMPOSITION HAVING SAME, USE THEREOF, AND THERAPEUTIC METHOD USING SAME
#25TRANSDERMAL TREATMENT FOR ERECTILE DYSFUNCTION
#26ENDODONTIC BIOFILM-ERADICATION TECHNIQUE UTILIZING A DUAL-SYSTEM INTRACANAL MEDICATION
#27TREATMENTS WITH NIROGACESTAT
#28DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
#29CRYSTAL FORM OF NIROGACESTAT DIHYDROBROMIDE, AND PREPARATION METHOD THEREFOR, AND USE THEREOF
#30SOLID STATE FORMS OF NIROGACESTAT SALTS
#31PHARMACEUTICAL COMPOSITION WITH ANALGESIC AND/OR ANTIPRURITIC FUNCTIONS AND APPLICATION THEREOF
#32COMPOSITIONS AND METHODS FOR INHIBITING PLpro PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-CoV-2 INFECTION
#33COMPOSITIONS AND TREATMENTS WITH NIROGACESTAT
#34MEDICAL COUNTER MEASURES INCLUDING DRY POWDER FORMULATIONS AND ASSOCIATED METHODS
#35COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF IMMUNOTHERAPIES AND VACCINES
#36AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#37AQUEOUS OPHTHALMIC SOLUTIONS OF PHENTOLAMINE AND MEDICAL USES THEREOF
#38HISTAMINE RECEPTOR AGONISTS FOR CANCER THERAPY IN CANCER PATIENTS UNRESPONSIVE TO CANCER IMMUNOTHERAPY AND WITH ELEVATED MYELOID DERIVED SUPPRESSOR CELLS
#39BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
#40MUSCLE REGENERATION PROMOTER
#41Bioactive polymeric dressing for accelerated wound closure
#42Treatments with nirogacestat
#43METHODS AND COMPOSITIONS FOR TREATING MYDRIASIS, GLAUCOMA, AND OTHER OCULARCONDITIONS
#44MODIFIED PROTEINS AND PROTEIN BINDERS
#45L-ERGOTHIONEINE-CONTAINING COMPOSITION
#46Treatments with nirogacestat
#47IMPROVED TREATMENT OF OVARIAN CANCER WITH NIROGACESTAT
#48COMBINATION THERAPIES FOR TREATMENT OF BCMA-RELATED CANCERS AND AUTOIMMUNE DISORDERS
#49Treatments with nirogacestat
#50Treatments with nirogacestat
#51Dry powder formulations of epinephrine and associated methods
#52COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#53COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION
#54Treatments with nirogacestat
#55CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
#56METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE
#57NERVE AGENT DECONTAMINATING AGENTS
#58CANNABIDIOL (CBD) BASED COMPOSITION AND METHOD FOR TREATING PAIN
#59GENETIC METHOD FOR DIAGNOSIS AND TREATMENT OF PRE AND POST CORONAVIRUS INFECTIONS
#60APPLICATION OF SMALL-MOLECULE COMPOUND IN PREPARATION OF ANTITUMOR DRUG
#61GAMMA SECRETASE MODULATORS FOR THE TREATMENT OF IMMUNE SYSTEM DYSFUNCTION
#62SYSTEMS, DEVICES, AND FORMULATIONS FOR TIME-PHASED HISTAMINE DELIVERY
#63SUBSTITUTED HETEROARYL COMPOUNDS AND USE THEREOF
#64CONJUGATES OF ACTIVE PHARMACEUTICAL INGREDIENTS
#65USE OF CANNABINOIDS IN TREATING ANTI-DEPRESSANT-INDUCED FEMALE SEXUAL DYSFUNCTION
#66ACIDIC CANNABINOIDS AND USES THEREOF FOR ENHANCING FEMALE SEXUAL FUNCTION OR TREATING FEMALE SEXUAL DISORDERS
#67Chlorinated tetralin compounds and pharmaceutical compositions
#68PHARMACEUTICAL COMPOSITIONS COMPRISING FLUBENDAZOLE
#69NOTCH SIGNALING INHIBITORS FOR TREATING OBESITY AND METABOLIC DISORDERS
#70Chlorinated tetralin compounds and pharmaceutical compositions
#71MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#72METHODS OF REDUCING POST-SURGICAL METASTASIS
#73DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
#74Dry powder formulations of epinephrine and associated methods
#75Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
#76Medical counter measures including dry powder formulations and associated methods
#77THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS
#78A COMBINATION OF FLAVONOIDS AND SPHINGOSINE 1 PHOSPHATE LYASE INHIBITORS FOR THE TREATMENT OF LUNG INFLAMMATION
#79A COMBINATION THERAPY WITH NIROGACESTAT AND A BCMA-DIRECTED THERAPY AND USES THEREOF
#80FORMS OF 5-({[2-AMINO-3-(4-CARBAMOYL-2,6-DIMETHYL-PHENYL)-PROPIONYL]-[1-(4-PHENYL-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-METHOXY-BENZOIC ACID
#81Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof
#82COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND GAMMA SECRETASE INHIBITORS
#83CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
#84Chlorinated tetralin compounds and pharmaceutical compositions
#85CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
#86ANTI-MSR1 ANTIBODIES AND METHODS OF USE THEREOF
#87Composition and methods for the treatment of myopia
#88Self-healing organic crystals
#89Methods and compositions for treatment of mydriasis
#90Methods and compositions for treatment of mydriasis
#91TOPICAL COMPOSITION
#92PERIPHERALLY ACTING CANNABIDIOL (CBD)-CONTAINING COMPOUNDS AND USES THEREOF FOR ENHANCING FEMALE SEXUAL FUNCTION OR TREATING FEMALE SEXUAL DISORDERS
#93Dry powder formulations of epinephrine and associated methods
#94GLP-1 COMPOUND
#95DOSING REGIMEN AND COMBINATION THERAPIES FOR MULTISPECIFIC ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN
#96METHODS OF TREATING BILE ACID DIARRHEA
#97Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
#98COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTION
#99ISOTOPE-ENRICHED 3-AMINO-1-PROPANESULFONIC ACID DERIVATIVES FOR THE TREATMENT OF CEREBROVASCULAR DISEASE
#100AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#101USING PARASYMPATHOMIMETIC DRUGS ALONE OR, IN COMBINATION WITH ONE OR MORE ALPHA AGONISTS IN PSEUDOPHAKIC PATIENTS, TO CREATE MULTI-FOCALITY
#102Aqueous ophthalmic solutions of phentolamine and medical uses thereof
#103COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR
#104Transdermal treatment for erectile dysfunction
#105Co-Administration of inhibitors to produce insulin producing gut cells
#106Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#107LOCALIZED ADMINISTRATION OF RNA MOLECULES FOR THERAPY
#108METHOD AND COMPOSITION EMBODIMENTS FOR TREATING ACUTE MYELOID LEUKEMIA
#109PHARMACEUTICALLY ACTIVE CANNABIS-BASED COMPOSITIONS AND METHODS OF USE FOR TREATING GASTROINTESTINAL CONDITIONS
#110Methods and compositions for treatment of glaucoma and related conditions
#111METHODS AND COMPOSITIONS FOR TREATMENT OF PRESBYOPIA, MYDRIASIS, AND OTHER OCULAR DISORDERS
#112Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
#113HISTAMINE DIHYDROCHLORIDE COMBINATIONS AND USES THEREOF
#114COMBINATION FOR TREATING CANCER
#115Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction
#116IMIDAZOLYL ETHANAMIDE PENTANDIOIC ACID FOR USE IN THERAPY OF SYMPTOMS RELATED TO EXPOSURE TO LETHAL RADIATION
#117MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#118MODULATORS OF THE INTEGRATED STRESS PATHWAY
#119POLYMORPHS OF 5-({[2-AMINO-3-(4-CARBAMOYL-2,6-DIMETHYL-PHENYL)-PROPIONYL]-[1-(4-PHENYL-1H-IMIDAZOL-2-YL)-ETHYL]-AMINO}-METHYL)-2-METHOXY-BENZOIC ACID
#120Compounds and methods for the targeted degradation of androgen receptor
#121SELECTIVE PRESENILIN-2 GAMMA-SECRETASE INHIBITORS
#122METHODS AND COMPOSITIONS FOR REDUCING RISK OF RELAPSE AND PROLONGING SURVIVAL IN ACUTE MYELOID LEUKEMIA
#123COMPOSITIONS AND METHODS FOR TREATING CANCER
#124Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof
#125Conjugates of active pharmaceutical ingredients
#126Bioactive polymeric dressing for accelerated wound closure
#127Intranasal Formulation of Epinephrine for the Treatment of Anaphylaxis
#128METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING METASTATIC TUMORS
#129METHODS FOR TREATING DEPENDENCE
#130LSD1 inhibitor and preparation method and application thereof
#131Compositions and methods of treatment of Ehlers-Danlos syndromes
#132Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#133Adamantane or Bicyclic Monoterpenoid Derivatives for Use in the Treatment of Leishmaniasis
#134CXCR4 antagonists with amino acid skeleton, preparation therefor and biomedical use thereof
#135Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
#136Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
#137METHODS OF DELAYING AND PREVENTING ACUTE MYELOID LEUKEMIA RELAPSE
#138Compositions and methods for treatment of inflammation
#139Composition and methods for the treatment of myopia
#140KCNQ2-5 CHANNEL ACTIVATOR
#1415,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases
#142COMPOUNDS AND COMPOSITIONS FOR EXTENDING LIFESPAN OF A SUBJECT
#143CELLS EXPRESSING A BCMA-TARGETING CHIMERIC ANTIGEN RECEPTOR, AND COMBINATION THERAPY WITH A GAMMA SECRETASE INHIBITOR
#144USE OF MICROBIAL METABOLITES FOR TREATING DISEASES
#145DBH inhibitors for treating or preventing memory loss
#146Anti-MSR1 antibodies and methods of use thereof
#147Combination therapies for treatment of BCMA-related cancers and autoimmune disorders
#148Aqueous ophthalmic solutions of phentolamine and medical uses thereof
#149Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#150SYNERGISTIC COMPOSITION FOR INHIBITING ADVANCED GLYCATION END PRODUCT CROSSLINKING
#151TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY
#152Uses of dopamine beta-hydroxylase (DBH) inhibitors and serotonin receptor (5-HT) antagonists for the treatment of cancer
#153Aqueous ophthalmic solutions of phentolamine and medical uses thereof
#1541,3-Dihydroimidazole-2-Thione Derivatives for Use in the Treatment of Pulmonary Arterial Hypertension and Lung Injury
#155Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#156Modulators of the integrated stress pathway
#157Compositions and methods for treating cancer
#158COMPOUNDS USEFUL FOR DECREASING INTERFERON LEVEL
#159CXCR4 receptor-binding compounds useful for increasing interferon level
#160Medicament
#161Method of Preparing Solid Dispersions of Active Pharmaceutical Ingredients
#162FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG
#163Methods for producing optically active valeric acid derivatives
#164Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
#165Method for binding active agents to activated autologous blood nosodes and device for performing said method
#166DBH inhibitors for treating memory loss
#167Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function
#168KCNQ2-5 channel activator
#169COMPOSITIONS AND METHODS FOR TREATING CYSTIC FIBROSIS
#170Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#171METHODS FOR RESTORATION OF HISTAMINE BALANCE
#172Compositions and methods for treatment of inflammation
#173Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#174Hepatitis C virus inhibitors
#175Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
#176Aqueous ophthalmic solutions of phentolamine and medical uses thereof
#177USE OF CYP EXPRESSION TO DIRECT THERAPEUTIC INTERVENTION IN CANCER
#178USE OF MICROBIAL METABOLITES FOR TREATING DISEASES
#179Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function
#180Compounds for use as therapeutic agents affecting P53 expression and/or activity
#181Therapeutic compounds and formulations for intranasal delivery
#182USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING
#183AMINO ALCOHOL DERIVATIVES FOR THE TREATMENT OF DEMYELINATING PERIPHERAL NEUROPATHIES
#184ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
#185Methods for producing optically active valeric acid derivatives
#1861,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injury
#187Intranasal formulation of epinephrine for the treatment of anaphylaxis
#188TREATMENT FOR CUTANEOUS T CELL LYMPHOMA
#189KCNQ2-5 channel activator
#190Solid pharmaceutical composition comprising amlodipine and losartan
#191Pharmaceutical formulations of xanthine or xanthine derivatives, and their use
#192Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to damage
#193Methods for producing optically active valeric acid derivatives
#194Methods for restoration of histamine balance
#195ARYLOXY PHENOXY ACRYLIC COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ACTIVE INGREDIENT
#196Therapeutic Treatment For Metabolic Syndrome, Type 2 Diabetes, Obesity, Or Prediabetes
#197Two part formulation system for ophthalmic delivery
#198Use of Glutaryl Histamine for the Treatment of Respiratory Tract Diseases
#199Stabilized multi-functional antioxidant compounds and methods of use
#200Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#201METHODS AND MATERIALS FOR TREATING HYPERTENSION
#202METHOD AND COMPOSITION FOR ENHANCEMENT OF MALE ERECTILE FUNCTION
#203Semicarbazide-sensitive amine oxidase inhibitors for use as analgesics in traumatic neuropathy and neurogenic inflammation
#204WOUND HEALING COMPOSITION
#205Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to damage
#206Method for preventing or treating diseases associated with a reduced density of interferon receptors
#207Method of inhibiting the glycation of nutrient and endogenous proteins and peroxidation of nutrient and endogenous lipids
#208PHARMACEUTICAL FORMULATIONS FOR TREATING MALE SEXUAL DYSFUNCTIONS
#209Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
#210Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#211Two part formulation system for ophthalmic delivery
#212Intranasal Formulation for the Treatment of Cardiopulmonary Resuscitation (CPR), Cardiac Life Support (CLS), Anaphylaxis and/or Anaphylactoid Reactions
#213Selective AT2 receptor agonists for use in treatment of cachexia
#214Compositions and methods for treatment of inflammation
#215Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
#216Cycloalkyl-diamines for neurodegenerative disorders
#217Methods and compositions for treating and preventing signs or symptoms of eye disease
#218Compositions and methods for treating or preventing metabolic syndrome disorders
#219Alkylamine derivative
#220Pharmaceutical composition for treating a microbial infection
#221Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
#222Therapeutic benefit of suboptimally administered chemical compounds
#223Inhibitors of the renal outer medullary potassium channel
#224SPRAYABLE OXYGENATED SALINE COMPOSITION AND METHOD FOR TREATING NASAL CONGESTION, ALLERGY, DRYNESS, EYE IRRITATION, THROAT IRRITATION, WOUNDS, AND SKIN AS APPLIED TO HUMAN TISSUES
#225Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury
#226METHODS OF USING HISTAMINE RECEPTOR AGONISTS AND ANTAGONISTS
#227Therapeutic compounds and methods
#2281,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injury
#229Aggrecanase inhibitors
#230System and method for treating erectile dysfunction
#231Hetero-Substituted Acetanilide Derivatives As Analgesic Agents
#232Histamine balance restoration methods
#233Method and agent for the treatment and prophylaxis of diseases caused by (+)RNA-containing viruses
#234Inhibitors targeting drug-resistant influenza A
#235Dual-acting imidazole antihypertensive agents
#236NEURONAL REGENERATION
#237METHOD FOR OPTIMIZING VISION
#238Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#239Fused ring compound for use as mineralocorticoid receptor antagonist
#240Methods and compositions for treating and preventing signs or symptoms of eye disease
#241Preservation of Ergothioneine
#242Dual-acting antihypertensive agents
#243Agent for the treatment of viral hepatitis C
#244DRUG DELIVERY SYSTEM FOR TREATING ERECTILE DYSFUNCTION
#245COMPOSITION AND METHODS FOR CELL MODULATION
#246OPHTHALMIC FORMULATIONS INCLUDING SELECTIVE ALPHA 1 ANTAGONISTS
#247Pharmaceutical formulations of xanthine or xanthine derivatives, and their use
#248Intranasal formulation of epinephrine for the treatment of anaphylaxis
#249TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY
#250Methods for restoration of histamine balance
#251Dual-acting imidazole antihypertensive agents
#252Use of RANK/RANKL antagonists for treating muscular dystrophy
#253Treating cancer with HSP90 inhibitory compounds
#254MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#255Opioid receptor modulator dosage formulations
#256Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
#257Aqueous ophthalmic solutions of phentolamine and medical uses thereof
#258Compounds for use as therapeutic agents affecting p53 expression and/or activity
#259Cycloalkyl-substituted imidazole derivative
#260Ophthalmic compositions comprising polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymers
#261METHOD OF TREATING MUSCULAR WEAKNESS COMPRISING ADMINISTERING A COMPOSITION COMPRISING AN EFFECTIVE AMOUNT OF HISTAMINE AND/OR SEROTONIN
#262Prostamides for the treatment of glaucoma and related diseases
#263Methods for treating dependence
#264Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
#265Family of polyamine arylethylamide compounds, and their cosmetic or dermocosmetic use
#266Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins
#267SILICONE-BASED OPHTHALMIC FORMULATIONS
#268METHOD FOR TREATING MACULAR DEGENERATION
#269METHOD FOR TREATING A NEURODEGENERATIVE DISORDER
#270Fused ring compound for use as mineralocorticoid receptor antagonist
#271METHODS AND COMPOSITIONS FOR TREATMENT OF DRUG ADDICTION
#272Agents, compositions, and methods for treating pruritus and related skin conditions
#273Pharmaceutical composition and method of treating a microbial infection with sulcotidil
#274Cycloalkyl-Substituted Imidazole Derivative
#275Dual inhibitors of farnesyltransferase and geranylgeranyltransferase I
#276Method for treating psoriasis
#277Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
#278Prophylactic or therapeutic agent for diabetes or obesity
#279Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
#280Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP
#281TWO PART FORMULATION SYSTEM FOR OPTHALMIC DELIVERY
#282TOPICAL TRANSDERMAL METHOD FOR DELIVERING NUTRIENTS THROUGH THE SKIN FOR EXPEDITED WOUND HEALING
#283Cycloalkyl-substituted imidazole derivative
#284MACROGOL 15 HYDROXYSTEARATE FORMULATIONS
#285DOSING REGIMENS AND METHODS FOR TREATING OR PREVENTING HEPATOCELLULAR CARCINOMA
#286Inhibitor of protein crosslinking and use of the same
#287Dual-acting antihypertensive agents
#288NON-AQUEOUS SILICONE-BASED OPHTHALMIC FORMULATIONS
#289SILICONE-BASED OPHTHALMIC FORMULATIONS
#290Use of inhibitors of the renin-angiotensin system
#291Dual-acting imidazole antihypertensive agents
#292METHODS FOR MODULATING METABOLIC AND CIRCADIAN RHYTHMS
#293COMPOSITION COMPRISING ALPHA-LIPOIC ACID AND CARNOSINE FOR TREATING THE PHANTOM LIMB SYNDROME
#294PRENYLTRANSFERASE INHIBITORS FOR OCULAR HYPERTENSION CONTROL AND THE TREATMENT OF GLAUCOMA
#295COMPOSITION COMPRISING THE PURIFIED EXTRACT OF BEE VENOM FOR PREVENTING AND TREATING DEGENERATIVE BRAIN DISEASE
#296COMPOSITION AND USE OF N-ALPHA-METHYLHISTAMINE DIHYDROCHLORIDE FOR THE REDUCTION OF OXYGEN RADICAL FORMATION
#297Method of stimulating the motility of the gastrointestinal system using ipamorelin
#298Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors
#299Dual-acting antihypertensive agents
#300Method and composition for enhancement of male erectile function